Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 80.20
+0.10 (0.12%)
Oct 28, 2025, 10:16 AM IDT
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 174.72 million as of October 28, 2025. Its market cap has increased by 32.29% in one year.
Market Cap
174.72M
Enterprise Value
227.26M
Revenue
-501.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
80.20
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 174.72M, an increase of 495.76%. That is a compound annual growth rate of 29.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2025 | 169.92M | 14.22% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | 93.74M | 338.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 71.30B |
| Danel (Adir Yeoshua) | 3.03B |
| Kamada | 1.29B |
| SofWave Medical | 1.07B |
| BrainsWay | 1.04B |
| Bait Bakfar | 1.03B |
| Ilex Medical | 735.73M |
| Novolog (Pharm-Up 1966) | 649.83M |